PRO/EDR> Antibiotic resistance – USA: (CA) MDR-Acinetobacter, bacteriophage therapy

Acinetobacter baumannii — United States
Scientists and physicians at University of California San Diego School of Medicine, working with colleagues at the U.S. Navy Medical Research Center – Biological Defense Research Directorate (NMRC-BDRD), Texas A&M University, a San Diego-based biotech and elsewhere, have successfully used an experimental therapy involving bacteriophages – viruses that target and consume specific strains of bacteria – to treat a patient near death from a multidrug-resistant bacterium.
Infected with a